【24h】

Immunotherapy With a Phleum pratense Allergen Extract Induces an Immune Response to a Grass-Mix Allergen Extract

机译:p草变应原提取物的免疫疗法诱导对草混合变应原提取物的免疫反应

获取原文
           

摘要

Background: Grass pollen allergy is one of the most common allergies worldwide, and patients often show sensitization to an array of phylogenetically related species.Objective: To determine the effect of specific immunotherapy (SIT) with Phleum pratense extract on induction of the immune response to a mixture composed of 5 grass pollen extracts.Methods: Forty-six adult patients suffering from rhinitis and sensitized to a mix of grass pollen allergen extracts were randomized 3:1 to receive a short course of SIT with P pratense or to an open control group without SIT. At baseline and after 3-4 months, we evaluated levels of specific immunoglobulin (Ig) E and IgG4, as well as the immediate and delayed cutaneous responses to the grass mix and P pratense. IgG4 to Lolium perenne was also determined.Results: Levels of IgE and IgG4 to grass mix and P pratense increased significantly during treatment (P.001). However, this increase was only significantly higher in the SIT group than in the control group for IgG4 (P.001). The levels of IgG4 to Phl p 5 and Lol p 5 were highly correlated (r=0.99, P.001). The immediate and delayed cutaneous responses were significantly diminished to both extracts after SIT (P.001).Conclusions: Patients with rhinoconjunctivitis diagnosed using skin prick testing with a grass mix allergen extract and treated with a short course of SIT based on a single species P pratense allergen extract are able to develop an immune response that targets not only the immunizing species, but also the grass mix allergen extract.Key words: Allergen. Grass pollen. Cross-reactivity. Specific immunotherapy (SIT).
机译:背景:草粉花粉过敏是世界上最常见的过敏症之一,患者通常表现出对一系列系统发生相关物种的致敏作用。目的:确定用Ph草提取物进行特异性免疫治疗(SIT)对诱导对花粉过敏的免疫反应的作用方法:将46名患有鼻炎且对混合花粉过敏原提取物敏感的成年患者随机分3:1接受短期PIT联合SIT治疗或开放对照组没有SIT。在基线和3-4个月后,我们评估了特异性免疫球蛋白(Ig)E和IgG4的水平,以及对草混合物和P pratense的即时和延迟皮肤反应。结果:在处理过程中,草混合物和P.pratense的IgE和IgG4水平显着增加(P <.001)。但是,对于IgG4,SIT组的这种增加仅显着高于对照组(P <.001)。 IgG4与Phl p 5和Lol p 5的水平高度相关(r = 0.99,P <.001)。 SIT后两种提取物的立即和延迟的皮肤反应均显着降低(P <.001)。结论:经皮肤点刺试验诊断为鼻结膜炎的患者使用草混合变应原提取物并经短程SIT治疗(基于单一物种) P.pratense过敏原提取物能够产生不仅针对免疫物种而且针对草混合过敏原提取物的免疫应答。关键词:过敏原。草花粉。交叉反应。特异性免疫疗法(SIT)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号